Loading...
A switch in RND3-RHOA signaling is critical for melanoma cell invasion following mutant-BRAF inhibition
BACKGROUND: The initial use of BRAF targeted therapeutics in clinical trials has demonstrated encouraging responses in melanoma patients, although a rise in drug-resistant cells capable of advancing malignant disease has been described. The current study uses BRAF(V600E )expressing WM793 melanoma ce...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3180434/ https://ncbi.nlm.nih.gov/pubmed/21917148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-10-114 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|